BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27902749)

  • 1. Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis.
    Chan H; Tang YL; Lv XH; Zhang GF; Wang M; Yang HP; Li Q
    PLoS One; 2016; 11(11):e0167346. PubMed ID: 27902749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age Related Characteristics Of Children And Adolescent With Henoch Schönlein Purpura And Systems Involvement: An Experience From Tertiary Care Center.
    Aziz DA; Siddiqui F; Siddiqui MT
    J Ayub Med Coll Abbottabad; 2022; 34(2):336-340. PubMed ID: 35576298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Hahn D; Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD005128. PubMed ID: 26258874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Henoch-Schönlein Purpura in Children: An Updated Review.
    Leung AKC; Barankin B; Leong KF
    Curr Pediatr Rev; 2020; 16(4):265-276. PubMed ID: 32384035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude].
    Wei H; ; ;
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):923-928. PubMed ID: 37807749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch-Schönlein Purpura.
    Karadağ ŞG; Çakmak F; Çil B; Tanatar A; Sönmez HE; Kıyak A; Yavuz S; Çakan M; Aktay Ayaz N
    Postgrad Med; 2021 Apr; 133(3):272-277. PubMed ID: 32772751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age of onset as a risk factor of renal involvement in Henoch-Schönlein purpura.
    Ghrahani R; Ledika MA; Sapartini G; Setiabudiawan B
    Asia Pac Allergy; 2014 Jan; 4(1):42-7. PubMed ID: 24527410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do practical laboratory indices predict the outcomes of children with Henoch-Schönlein purpura?
    Ekinci RMK; Balci S; Sari Gokay S; Yilmaz HL; Dogruel D; Altintas DU; Yilmaz M
    Postgrad Med; 2019 May; 131(4):295-298. PubMed ID: 31021301
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
    Li MM; Liu N; Zhagn M; Xue HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal Henoch-Schönlein purpura successfully treated with Mycophenolate Mofetil: Description of 2 case reports.
    Gicchino MF; Iafusco D; Marrapodi MM; Melone R; Cuomo G; Zanfardino A; Del Giudice EM; Olivieri AN
    Medicine (Baltimore); 2021 Jan; 100(1):e24093. PubMed ID: 33429774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study.
    Wang K; Sun X; Cao Y; Dai L; Sun F; Yu P; Dong L
    Medicine (Baltimore); 2018 Sep; 97(38):e12520. PubMed ID: 30235770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification.
    Çakıcı EK; Gür G; Yazılıtaş F; Eroğlu FK; Güngör T; Arda N; Orhan D; Özalp Ateş FS; Bülbül M
    Clin Exp Nephrol; 2019 Jul; 23(7):939-947. PubMed ID: 30895528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.
    Zhu Y; Dong Y; Wu L; Deng F
    BMC Pediatr; 2019 Nov; 19(1):409. PubMed ID: 31684904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children?
    Kisla Ekinci RM; Balcı S; Mart OO; Tumgor G; Yavuz S; Celik H; Dogruel D; Altintas DU; Yilmaz M
    Rheumatol Int; 2019 Feb; 39(2):317-322. PubMed ID: 30101368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein purpura.
    Ma DQ; Li Y; Han ZG; Zheng M; Xu N; Fan XJ
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3894-3899. PubMed ID: 28975974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
    Purevdorj N; Mu Y; Gu Y; Zheng F; Wang R; Yu J; Sun X
    Clin Biochem; 2018 Feb; 52():167-170. PubMed ID: 29129626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between adult and pediatric onset Henoch-Schonlein purpura from North India.
    Gupta V; Aggarwal A; Gupta R; Chandra Chowdhury A; Agarwal V; Lawrence A; Misra R
    Int J Rheum Dis; 2018 Jan; 21(1):292-298. PubMed ID: 29115055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity increases the risk of renal involvement in children with Henoch-Schönlein purpura.
    Zhao YL; Liu ZJ; Bai XM; Wang YC; Li GH; Yan XY
    Eur J Pediatr; 2015 Oct; 174(10):1357-63. PubMed ID: 25899072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for renal involvement in Henoch-Schönlein purpura.
    Kim WK; Kim CJ; Yang EM
    J Pediatr (Rio J); 2021; 97(6):646-650. PubMed ID: 33722533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of neutrophil-to-lymphocyte ratio and mean platelet volume in pediatric Henoch-Schonlein Purpura: a meta-analysis.
    Li B; Ren Q; Ling J; Tao Z; Yang X; Li Y
    Bioengineered; 2021 Dec; 12(1):286-295. PubMed ID: 33412982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.